LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
Mai S, Hodges A, Chen HM, Zhang J, Wang YL, Liu Y, Nakatsu F, Wang X, Fang J, Xu Y, Davidov V, Kang K, Pingali SR, Ganguly S, Suzuki M, Konopleva M, Prinzing B, Zu Y, Gottschalk S, Lu Y, Chen SH, Pan PY.
Mai S, et al.
Cancer Res. 2023 Dec 15;83(24):4047-4062. doi: 10.1158/0008-5472.CAN-22-2483.
Cancer Res. 2023.
PMID: 38098451